Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125202681 | 12520268 | 1 | I | 20160627 | 20160701 | 20160701 | EXP | CA-BAUSCH-BL-2016-015331 | BAUSCH AND LOMB | 27.00 | YR | F | Y | 0.00000 | 20160701 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125202681 | 12520268 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 40069 | |||||||||||
| 125202681 | 12520268 | 2 | SS | MAGNESIUM | MAGNESIUM | 1 | Unknown | 0 | |||||||||||
| 125202681 | 12520268 | 3 | SS | CLOBAZAM | CLOBAZAM | 1 | Unknown | 0 | TABLET | ||||||||||
| 125202681 | 12520268 | 4 | SS | ISOFLURANE USP | ISOFLURANE | 1 | 0 | LIQUID | |||||||||||
| 125202681 | 12520268 | 5 | SS | KETAMINE HYDROCHLORIDE INJECTION USP | KETAMINE HYDROCHLORIDE | 1 | Intramuscular | 0 | SOLUTION | ||||||||||
| 125202681 | 12520268 | 6 | SS | MAGNESIUM SULFATE. | MAGNESIUM SULFATE | 1 | Unknown | 0 | |||||||||||
| 125202681 | 12520268 | 7 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Intramuscular | 0 | SOLUTION | ||||||||||
| 125202681 | 12520268 | 8 | SS | OXCARBAZEPINE. | OXCARBAZEPINE | 1 | Unknown | 0 | |||||||||||
| 125202681 | 12520268 | 9 | SS | PENTOBARBITAL. | PENTOBARBITAL | 1 | Unknown | 0 | |||||||||||
| 125202681 | 12520268 | 10 | SS | PROPOFOL INJECTION | PROPOFOL | 1 | Unknown | 0 | EMULSION | ||||||||||
| 125202681 | 12520268 | 11 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | 0 | |||||||||||
| 125202681 | 12520268 | 12 | SS | VALPROIC ACID. | VALPROIC ACID | 1 | Unknown | 0 | |||||||||||
| 125202681 | 12520268 | 13 | SS | KEPPRA | LEVETIRACETAM | 1 | Unknown | 0 | TABLET | ||||||||||
| 125202681 | 12520268 | 14 | SS | VIMPAT | LACOSAMIDE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125202681 | 12520268 | 1 | Status epilepticus |
| 125202681 | 12520268 | 2 | Product used for unknown indication |
| 125202681 | 12520268 | 3 | Status epilepticus |
| 125202681 | 12520268 | 4 | Status epilepticus |
| 125202681 | 12520268 | 5 | Status epilepticus |
| 125202681 | 12520268 | 6 | Status epilepticus |
| 125202681 | 12520268 | 7 | Status epilepticus |
| 125202681 | 12520268 | 8 | Product used for unknown indication |
| 125202681 | 12520268 | 9 | Status epilepticus |
| 125202681 | 12520268 | 10 | Status epilepticus |
| 125202681 | 12520268 | 11 | Status epilepticus |
| 125202681 | 12520268 | 12 | Status epilepticus |
| 125202681 | 12520268 | 13 | Status epilepticus |
| 125202681 | 12520268 | 14 | Status epilepticus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125202681 | 12520268 | DE |
| 125202681 | 12520268 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125202681 | 12520268 | Arrhythmia | |
| 125202681 | 12520268 | Blood creatine phosphokinase increased | |
| 125202681 | 12520268 | Gene mutation | |
| 125202681 | 12520268 | Metabolic acidosis | |
| 125202681 | 12520268 | Mitochondrial DNA mutation | |
| 125202681 | 12520268 | Propofol infusion syndrome | |
| 125202681 | 12520268 | Shock | |
| 125202681 | 12520268 | Status epilepticus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |